SOLANA BEACH, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Bridgetech Holdings
International, Inc. (OTC: BGTH), a company focused on maximizing the potential
of emerging healthcare products and services in China and the U.S., today
announced the execution of an exclusive license agreement in the field of
human diagnostics with the University of Texas M. Anderson Cancer Center,
ranked the nation's number one or number two cancer hospital by U.S. News
and World Report's "America's Best Hospitals" survey for the 16th year in
a row.
The initial product under this agreement is a prognostic to identify women
who are at increased risk of developing recurrent cervical cancer. By allowing
doctors to determine certain cell-mediated immune responses in a woman, they
can then increase the frequency and types of testing done to ensure that
any potential cervical cancer recurrence is detected as quickly as possible.
Bridgetech has secured exclusive, worldwide distribution rights to this
prognostic in the field of human diagnostics and will perform clinical trials
through the Bridgetech CRO in order to facilitate obtaining regulatory approval
in China.
New Cancers
New Approach Prevents Skin Cancer Using Photodynamic Therapy (PDT)
Every year there are more new cases of skin cancer than breast, prostate,
lung and colon cancers combined. One in 5 Americans will get skin cancer
in their lifetime. 90% of skin cancers are caused by excessive sun exposure,
yet fewer than 33 percent of adults, adolescents, and children routinely
use sun protection.
Cancer prevention and early detection techniques could eliminate up to 100,000
cancer cases and 60,000 US cancer deaths each year. New technologies in the
evaluation and treatment of sun damaged skin could have a positive impact
on changing these statistics.
The same sunny weather that attracts so many tourists and new residents to
the sun-belt also increases the risk of skin cancer. The effects of chronic
sun exposure result in superficial sun spots that are visible and also invisible
changes that occur under the skins surface. Ultraviolet photography
and photodynamic therapy (PDT) are two recent developments that should help
in the early detection and treatment of both types of pre-cancerous skin
lesions.
Early Detection with UV Photography Ultraviolet (UV) photography offers a
very useful screening tool to help the skilled physician detect sun damaged
skin that may not be visible upon a routine examination. Visual inspection
can only detect changes on the skins surface, but damage due to sun
exposure occurs beneath the outer layer of skin,
The UV camera briefly shines ultraviolet light on the face. UV light is able
to penetrate 1.5-2.0 millimeters under the visible dead layer of skin and
focus on the actual living portion where sun damage originates. The advantage
to the doctor and the patient is that this technology allows for much earlier
detection of skin problems before they develop into pre-cancers that are
visible on the skins surface. After finishing the treatment plan, the doctor
should take another UV photo to verify the treatment efficacy. UV photography
also helps evaluate other skin conditions including acne, oil balance, hydration,
inflammation, growths, fungi, pH, and thin skin due to reduced collagen which
makes it an ideal tool to evaluate all problem skin.
After the damage to the deeper layers of skin, superficial signs of sun damage
may eventually appear on the surface. The most common surface lesion is known
as actinic keratoses (AK). AKs usually appear as rough or scaly patches.
They may also flake, crust, and may temporarily disappear and then return.
An AK is most likely to appear on the face, ears, scalp, neck, backs of the
hands and forearms, shoulders, and lips - the parts of the body most often
exposed to sunshine. The scaly patch may be light or dark, tan, pink, red,
or a combination of these or the same color as your skin.
It is estimated that 10-20% of untreated AKs will develop into squamous cell
cancers. If treated early, almost all AKs can be eliminated without becoming
skin cancers. If you have AKs, it indicates that you have sustained sun damage
and have a higher risk for developing all types of skin cancer - not just
squamous cell carcinoma.
The more keratoses a person has, the greater the chance that one or more
may turn into skin cancer. People may also have up to 10 times as many
subclinical (invisible) lesions as visible, surface lesions. These invisible
lesions were undetectable until the development of the UV camera.
Treatment options The most common treatment options for AKs have traditionally
involved topical ointment 5-FU (Effudex), laser resurfacing, or chemical
peels. To avoid the prolonged recovery period and possible scarring associated
with these techniques, photodynamic therapy has been developed.
Photodynamic therapy (PDT) is the treatment of choice for the invisible deeper
sun damage as well as the visible pre-cancerous AK lesions. PDT involves
a two step process that has been proven effective in clinical testing. This
treatment cleared 100% of the AKs in 2/3 of the patients after one treatment.
The first step is the application of a topical solution called Levulan. Abnormal
cells have a much greater affinity for the solution and absorb it while the
healthy cells do not. The solution is left on for an incubation period lasting
anywhere from 15 minutes to 18 hours.
The second step of PDT is to apply a concentrated light source to activate
the chemical reaction which destroys the abnormal cells. Since the solution
is absorbed only in the damaged cells, the healthy cells are not affected.
This process can cause a mild burning sensation during the treatment. Usually,
this improves immediately after treatment and ends within 24 hours.
Following the treatment, most patients experience mild swelling, redness,
and a peeling of the AK lesions and the surrounding tissue. Patients choosing
a more aggressive treatment will experience more peeling and/or crusting
of the damaged skin that resolves within in one or two weeks. The doctor
can easily control the severity of these reactions by limiting the incubation
period and the amount of exposure to the light source.
Patients not willing to experience a prolonged recovery time after the procedure
may choose a more mild treatment and return to work after a day or two. The
tradeoff is that they will require more treatments to achieve the same clinical
results.
In addition to eliminating AKs and the subsurface skin damage, PDT has also
been effective in improving the appearance of the skin by greatly reducing
moderate to severe acne (including cystic acne), reducing color splotches,
lessening the fine lines, and decreasing pore size.
Anyone who currently has, has had, or wants to prevent AKs or pre-cancerous
skin lesions should be evaluated and treated using UV photography and
photodynamic therapy (PDT). Once a person has been successfully treated
using this approach, it is recommended they return for a yearly follow up
to prevent future problems.
William Nelson, NMD is a Naturopathic Medical Doctor and a member of the
American Academy of Aesthetic Medicine. Dr. Nelson specializes in treating
problem skin, reducing cellulite, and obesity by combining the latest medical
advances with safe, non-invasive natural therapies to improve the looks and
the health of his clients. Dr. Nelson is accepting new patients in his
Scottsdale. He can be reached at (480) 612-5048.
http://www.iclearacne.com
DISCLAIMER
- Please note that all articles on this web site does not constitute
professional advice. All articles are intended to provide a general view
of many topical subjects from a variety of sources. We are not responsible
for the content or any sponsored links that you may choose to visit from
this web site. We suggest you to consult a solicitor and your doctor for
advice relevant to you own situation before making any important decisions.
The author is not an expert in any given field. By printing, downloading,
or using you agree to our full terms. Below is a summary of some of the terms.
If you do not agree to the full terms, do not use the information. We are
only publishers of this material, not authors. Information may have errors
or be outdated. Some information is from historical sources or represents
opinions of the author. It is for research purposes only. The information
is "AS IS", "WITH ALL FAULTS". User assumes all risk of use, damage, or injury.
You agree that we have no liability for any damages. We are not liable for
any consequential, incidental, indirect, or special damages. You indemnify
us for claims caused by you.